Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Potential of PSMA as a Vascular Target in TNBC.
Cells. 2023 Feb 8;12(4):551. doi: 10.3390/cells12040551.
Cells. 2023.
PMID: 36831218
Free PMC article.
Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target.
Heesch A, Maurer J, Stickeler E, Beheshti M, Mottaghy FM, Morgenroth A.
Heesch A, et al.
Cells. 2020 Oct 21;9(10):2334. doi: 10.3390/cells9102334.
Cells. 2020.
PMID: 33096754
Free PMC article.
Review.
Item in Clipboard
Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Schilling S, Pradhan A, Heesch A, Helbig A, Blennow K, Koch C, Bertgen L, Koo EH, Brinkmalm G, Zetterberg H, Kins S, Eggert S.
Schilling S, et al. Among authors: heesch a.
Acta Neuropathol Commun. 2023 Jun 1;11(1):87. doi: 10.1186/s40478-023-01577-y.
Acta Neuropathol Commun. 2023.
PMID: 37259128
Free PMC article.
Item in Clipboard
The Rab5 activator RME-6 is required for amyloid precursor protein endocytosis depending on the YTSI motif.
Eggert S, Gruebl T, Rajender R, Rupp C, Sander B, Heesch A, Zimmermann M, Hoepfner S, Zentgraf H, Kins S.
Eggert S, et al. Among authors: heesch a.
Cell Mol Life Sci. 2020 Dec;77(24):5223-5242. doi: 10.1007/s00018-020-03467-1. Epub 2020 Feb 17.
Cell Mol Life Sci. 2020.
PMID: 32065241
Free PMC article.
Item in Clipboard
The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer.
Heesch A, Florea A, Maurer J, Habib P, Werth LS, Hansen T, Stickeler E, Sahnoun SEM, Mottaghy FM, Morgenroth A.
Heesch A, et al.
Breast Cancer Res. 2024 Feb 20;26(1):30. doi: 10.1186/s13058-024-01787-9.
Breast Cancer Res. 2024.
PMID: 38378689
Free PMC article.
Item in Clipboard
Cite
Cite